Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression

International Journal of Cardiology

Volumn 154, Issue 1, 2012, Pages 9-13

  Millar, Kyle ^a   Manlhiot, Cedric ^a   Yeung, Rae S M ^a   Somji, Zeeshanefatema ^a   McCrindle, Brian W ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Coronary artery abnormalities; Corticosteroids; Kawasaki disease; Pediatrics

Indexed keywords

ALBUMIN; CORTICOSTEROID; HEMOGLOBIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ADOLESCENT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG RESPONSE; DRUG USE; FEMALE; FEVER; FOLLOW UP; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; RIGHT CORONARY ARTERY; SCHOOL CHILD; SCORING SYSTEM; THROMBOCYTE COUNT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDNISONE; RETROSPECTIVE STUDIES;

EID: 82655170525     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.070     Document Type: Article

References (41)

1. H. Kato, T. Sugimura, and T. Akagi Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients Circulation 94 6 1996 1379 1385 (Pubitemid 26307269)
2. Y. Sasaguri, and H. Kato Regression of aneurysms in Kawasaki disease: a pathological study J Pediatr 100 2 1982 225 231 (Pubitemid 12165830)
3. A. Suzuki, S. Miyagawa-Tomita, and K. Komatsu Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study Circulation 101 25 2000 2935 2941 (Pubitemid 30415884)
4. D.M. Levy, E.D. Silverman, and M.P. Massicotte Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease J Rheumatol 32 5 2005 928 934 (Pubitemid 40676506)
5. M. Takahashi, W. Mason, and A.B. Lewis Regression of coronary aneurysms in patients with Kawasaki syndrome Circulation 75 2 1987 387 394 (Pubitemid 17007345)
6. Manlhiot C., Brandao L.R., Somji Z., et al. Long-term anticoagulation in Kawasaki Disease: initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities. Pediatr Cardiol 2010;31(6):834-42.
7. R.V. Williams, W.Y. Tcheng, and L. Minich Anticoagulation in the acute and long-term management of Kawasaki disease Prog. Pediatr. Cardiol. 19 2 2004 179 188 (Pubitemid 39485656)
8. R.V. Williams, V.M. Wilke, and L.Y. Tani Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics 109 1 2002 E4
9. C.A. Wallace, J.W. French, and S.J. Kahn Initial intravenous gammaglobulin treatment failure in Kawasaki disease Pediatrics 105 6 2000 E78
10. D.A. Wright, J.W. Newburger, and A. Baker Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids J Pediatr 128 1 1996 146 149 (Pubitemid 26028974)
11. R.C. Dale, M.A. Saleem, and S. Daw Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin J Pediatr 137 5 2000 723 726
12. K. Hashino, M. Ishii, and M. Iemura Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy Pediatr Int 43 3 2001 211 217 (Pubitemid 32640933)
13. J.W. Newburger, M. Takahashi, and M.A. Gerber Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association Circulation 110 17 2004 2747 2771 (Pubitemid 39453026)
14. H. Kato, S. Koike, and T. Yokoyama Kawasaki disease: effect of treatment on coronary artery involvement Pediatrics 63 2 1979 175 179 (Pubitemid 9083134)
15. K. Furusho, T. Kamiya, and H. Nakano High-dose intravenous gammaglobulin for Kawasaki disease Lancet 2 8411 1984 1055 1058 (Pubitemid 15211522)
16. K. Takahashi, T. Oharaseki, and M. Wakayama Pathological study of ruptured coronary artery aneurysms of Kawasaki disease (KD) Abstracts from the 2nd World Congress of Pediatric Cardiology and Cardiac Surgery 11-15 May 1997 202
17. N. Suzuki, M. Seguchi, and C. Kouno Rupture of coronary aneurysm in Kawasaki disease Pediatr Int 41 3 1999 318 320 (Pubitemid 29272401)
18. S. Naoe, K. Takahashi, and H. Masuda Kawasaki disease. With particular emphasis on arterial lesions Acta Pathol Jpn 41 11 1991 785 797
19. C. Manlhiot, K. Millar, and F. Golding Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease Pediatr Cardiol 31 2 2009 242 249
20. J.W. Newburger, M. Takahashi, and M.A. Gerber Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association Pediatrics 114 6 2004 1708 1733 (Pubitemid 41754943)
21. B.W. McCrindle, J.S. Li, and L.L. Minich Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements Circulation 116 2 2007 174 179 (Pubitemid 47057523)
22. S.T. Shulman Is there a role for corticosteroids in Kawasaki disease? J Pediatr 142 6 2003 601 603 (Pubitemid 36737158)
23. Y. Okada, M. Shinohara, and T. Kobayashi Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children J Pediatr 143 3 2003 363 367 (Pubitemid 37188322)
24. P.P. Youssef, D.R. Haynes, and S. Triantafillou Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis Arthritis Rheum 40 8 1997 1400 1408 (Pubitemid 27430950)
25. B.N. Cronstein, S.C. Kimmel, and R.I. Levin A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1 Proc Natl Acad Sci USA 89 21 1992 9991 9995
26. A.H. Rowley, S.T. Shulman, and C.A. Mask IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease J Infect Dis 182 4 2000 1183 1191
27. T.J. Brown, S.E. Crawford, and M.L. Cornwall CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease J Infect Dis 184 7 2001 940 943 (Pubitemid 32881104)
28. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 3 2002 251 262 (Pubitemid 34633925)
29. R. Pyo, J.K. Lee, and J.M. Shipley Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms J Clin Invest 105 11 2000 1641 1649 (Pubitemid 30390315)
30. R.W. Thompson, and W.C. Parks Role of matrix metalloproteinases in abdominal aortic aneurysms Ann NY Acad Sci 800 1996 157 174 (Pubitemid 27028953)
31. P.J. Gavin, S.E. Crawford, and S.T. Shulman Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease Arterioscler Thromb Vasc Biol 23 4 2003 576 581 (Pubitemid 36438068)
32. S.K. Moon, B.Y. Cha, and C.H. Kim ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway J Cell Physiol 198 3 2004 417 427
33. T. Freestone, R.J. Turner, and A. Coady Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm Arterioscler Thromb Vasc Biol 15 8 1995 1145 1151
34. A.C. Lau, T.T. Duong, and E.A. Christie Matrix Metalloproteinase-9- mediated extracellular matrix degradation leads to coronary artery aneurysm formation in a model of Kawasaki disease Arthritis Rheum 52 9 2005 223 224
35. J.S. Hui-Yuen, T.T. Duong, and R.S. Yeung TNF-{alpha} is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease J Immunol 176 10 2006 6294 6301
36. A.C. Lau, H. Rosenberg, and T.T. Duong Elastolytic matrix metalloproteinases and coronary outcome in children with Kawasaki disease Pediatr Res 61 6 2007 710 715 (Pubitemid 46800281)
37. T. Rhen, and J.A. Cidlowski Antiinflammatory action of glucocorticoids-new mechanisms for old drugs N Engl J Med 353 16 2005 1711 1723
38. M. Lowenberg, A.P. Verhaar, and G.R. van den Brink Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression Trends Mol Med 13 4 2007 158 163 (Pubitemid 46498830)
39. T. Sabharwal, C. Manlhiot, and S.M. Benseler Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease Am J Cardiol 104 12 2009 1743 1747
40. C. Manlhiot, R.S. Yeung, and N.A. Clarizia Kawasaki disease at the extremes of the age spectrum Pediatrics 124 3 2009 e1 e6
41. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150